Feeding rats a semipurified diet containing casein as a protein source
results in severe gastrointestinal (GI) toxicity when the chemotherap
eutic drug methotrexate (MTX) is given. However, when soy concentrate
protein is used in place of casein, rats are completely protected from
toxicity. The purpose of this study was to determine whether soy prot
ein was also protective against two other chemotherapeutic agents, 5-f
luorouracil (5-FU) and cyclophosphamide (CY), which are routinely used
in a multidrug regimen with MTX in a clinical setting. Three diets we
re tested; they consisted of a control complex diet (rat chow) and two
semipurified diets containing casein or soy concentrate as the protei
n fraction given to non-tumor-bearing rats receiving a single injectio
n of 5-PU or CY at three different levels (Experiment I: 5-FU: 100, 26
0, and 420 mg/kg; Experiment II: CY: 120, 180, and 240 mg/kg). Each di
et was fed to seven rats for seven days before injection and seven day
s after injection. Food intake decreased at Day 3 in all groups receiv
ing 5-FU (35-90% reduction from preinjection level), with the greatest
decrease associated with the group receiving the highest drug level.
Animals fed the control diet ate consistently less than animals fed th
e other two diets regardless of the drug level. Intake was not signifi
cantly different between the casein and soy concentrate groups at any
drug level. Animals gained weight on the low-dose treatment regardless
of diets. At 260 and 420 mg/kg 5-FU, all diet groups lost weight, but
the difference was significant only between the control and the two o
ther diets (p < 0.05). Diarrhea was absent in the casein diet groups,
regardless of drug dose, and present in the other diet groups. Food in
take decreased on Day I for all groups receiving CY; At any dose, the
control diet group maintained a greater intake on Day 1 than the other
two diet groups. The difference in intake was significant between the
control and the two other diet groups at low dose, between the contro
l and the casein diet groups at 180 mg/kg, and between the control and
the soy concentrate diet groups at high dose (p < 0.05). Ah animals l
ost weight regardless of diet and drug dose. A third experiment was co
nducted to evaluate histological damage to the intestine when these th
ree diets were fed to animals injected with 420 mg/kg 5-FU. This exper
iment was conducted in the same manner as Experiment I, except animals
were sacrificed on Day 3 after injection to remove jejunal samples. C
rypt necrosis and debris occurred in all groups receiving 5-FU. Villus
height was decreased in all groups, with a less reduction in the case
in diet group, and the difference was significant with the 2 other die
t groups (p < 0.05). Results indicate that none of the three diets pro
moted significant protection against 5-FU- or CY-induced toxicity.